June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Analysis of the covalent high molecular weight protein complex containing optineurin and its relationship with glaucoma
Author Affiliations & Notes
  • Jie Gao
    Department of Photomedical Genomics, Basic Medical Photonics Laboratory, Medical Photonics Research Center, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Department of Ophthalmology, Hamamatsu University School of Medicine, Hamamatsu, Japan
  • Masafumi Ohtsubo
    Department of Photomedical Genomics, Basic Medical Photonics Laboratory, Medical Photonics Research Center, Hamamatsu University School of Medicine, Hamamatsu, Japan
  • Yoshihiro Hotta
    Department of Ophthalmology, Hamamatsu University School of Medicine, Hamamatsu, Japan
  • Shinsei Minoshima
    Department of Photomedical Genomics, Basic Medical Photonics Laboratory, Medical Photonics Research Center, Hamamatsu University School of Medicine, Hamamatsu, Japan
  • Footnotes
    Commercial Relationships Jie Gao, None; Masafumi Ohtsubo, None; Yoshihiro Hotta, None; Shinsei Minoshima, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 1607. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jie Gao, Masafumi Ohtsubo, Yoshihiro Hotta, Shinsei Minoshima; Analysis of the covalent high molecular weight protein complex containing optineurin and its relationship with glaucoma. Invest. Ophthalmol. Vis. Sci. 2013;54(15):1607.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: We are analyzing the function of optineurin (OPTN) to elucidate the onset mechanism of glaucoma. It was reported that the physiologically existing form of OPTN in cultured cells is oligomer, which is dissociated into monomers when detected by western blotting (WB) using denatured gels under reducing condition. We recently found an OPTN-containing high molecular weight complex (HMC) induced by H2O2 treatment of cells using the same detection method and named it covalent HMC. The aim of this study is to analyze the covalent HMC and its relationship with glaucoma pathogenesis.

Methods: Plasmids to express wild-type (Wt) and a series of mutant OPTNs were constructed and transfected into HeLaS3 or NIH3T3 cells. The mutants include the glaucoma causative ones, H26D, E50K, M98K, H486R, and R545Q, as well as a designed mutation D474N which was reported to abolish the binding with ubiquitin (Ub) and a truncated mutant LcUBD (lacking Ub-Binding Domain). The HMC formed in the cells transfected with these constructs with/without stimuli was detected by WB using denatured gels under reducing condition. Dual-luciferase reporter assay was applied for measuring TNFα-induced NF-κB activity (TINA) to examine if the inhibitory effect of OPTN on TINA is abolished by LcUBD and D474N.

Results: 1. The covalent HMC induced by H2O2 treatment of cells was probably the covalent trimer of OPTN (cOPTN3) according to the estimated molecular weight from the WB results; 2. The formation of cOPTN3 was detected in not only Wt but also all of the point mutants including D474N when cells were stimulated with H2O2; 3. Only in the case of E50K, the formation of cOPTN3 was induced without H2O2 addition; 4. cOPTN3 was not detected in LcUBD with/without H2O2 treatment; 5. TNFα did not induce the formation of cOPTN3.

Conclusions: 1. Our results suggested that physiologically existing non-covalent OPTN oligomer is cross-linked each other with some covalent bond under oxidative environment with unknown mechanism. 2. E50K is a distinct mutation which possibly produces the similar intracellular condition as H2O2 treatment, suggesting a possible relationship of E50K with the severity of glaucoma phenotype. 3. The UBD is necessary for cOPTN3 formation, but the site essential for Ub binding seems unnecessary. 4. cOPTN3 is not involved in TNFα-induced NF-κB signaling pathway.

Keywords: 660 proteins encoded by disease genes • 659 protein structure/function • 634 oxidation/oxidative or free radical damage  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×